Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Bluebird bio Inc shares valued at $405 were sold by Obenshain Andrew on Dec 10 ’24. At $0.42 per share, Obenshain Andrew sold 971 shares. The insider’s holdings dropped to 374,247 shares worth approximately $3.45 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Colvin Richard A sold 2,824 shares, netting a total of over 1,178 in proceeds. Following the sale of shares at $0.42 each, the insider now holds 165,544 shares.
Before that, Colvin Richard A had added 2,824 shares to its account. In a trade valued at $1,271, the Officer bought Bluebird bio Inc shares for $0.45 each.
As published in a research note from JP Morgan on November 15, 2024, Bluebird bio Inc [BLUE] has been rated down from a Neutral to an Underweight. Analysts at BofA Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid November. As of August 15, 2024, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for BLUE. Earlier on December 11, 2023, HSBC Securities downgraded its rating. Their new recommendation was “a Reduce” for BLUE stock which previously was a “a Hold”.
Analyzing BLUE Stock Performance
During the last five days, there has been a surge of approximately 21.45%. Over the course of the year, Bluebird bio Inc shares have dropped approximately -66.56%. Shares of the company reached a 52-week high of $38.40 on 02/27/24 and a 52-week low of $5.80 on 11/21/24. A 50-day SMA is recorded $8.61, while a 200-day SMA reached $16.35. Nevertheless, trading volume fell to 0.63 million shares from 1.11 million shares the previous day.
Support And Resistance Levels for Bluebird bio Inc (BLUE)
According to the 24-hour chart, there is a support level at 8.31, which, if violated, would cause prices to drop to 7.40. In the upper region, resistance lies at 9.87. The next price resistance is at 10.52. RSI (Relative Strength Index) is 53.32 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.17, which suggests the price will decrease in the coming days. Percent R is at 65.43%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
